Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Net Cash Flow (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Net Cash Flow for 2 consecutive years, with -$7.7 million as the latest value for Q4 2023.

  • On a quarterly basis, Net Cash Flow rose 11.0% to -$7.7 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$9.3 million, a 97.18% increase, with the full-year FY2024 number at -$14.9 million, down 59.85% from a year prior.
  • Net Cash Flow was -$7.7 million for Q4 2023 at LENZ Therapeutics, up from -$31.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $70.4 million in Q1 2023 to a low of -$191.9 million in Q1 2022.